California 2011-2012 Regular Session

California Senate Bill SB616

Introduced
2/18/11  
Introduced
2/18/11  
Refer
3/3/11  
Refer
3/3/11  
Refer
3/22/11  
Refer
3/31/11  
Refer
3/31/11  
Report Pass
4/25/11  
Refer
4/26/11  
Refer
4/26/11  
Refer
1/4/12  
Refer
1/5/12  
Refer
1/5/12  
Report Pass
1/11/12  
Report Pass
1/11/12  
Engrossed
1/17/12  
Refer
6/25/12  
Refer
6/25/12  
Refer
6/26/12  
Refer
6/26/12  
Refer
6/27/12  
Refer
6/27/12  
Report Pass
7/3/12  
Report Pass
7/3/12  
Refer
8/27/12  

Caption

Controlled substances: reporting.

Impact

The implications of SB616 on state laws are significant, as it seeks to amend existing regulations to create a more structured system for the management of controlled substances. The bill may lead to stricter penalties for non-compliance and could result in increased administrative burdens on healthcare providers and pharmacists who must ensure they are in accordance with the new reporting standards. This move is largely seen as a proactive step to combat drug abuse within the state, which has been a growing concern in recent years.

Summary

SB616 is a bill that focuses on the reporting requirements for controlled substances. This legislative measure aims to tighten the oversight of controlled substances within the state, ensuring that practitioners and pharmacies adhere to standardized reporting protocols. The bill not only seeks to enhance accountability among healthcare providers and pharmacists but also addresses issues of misuse and abuse of prescription drugs, providing a framework for more consistent tracking of these substances.

Sentiment

The sentiment surrounding SB616 tends to be supportive among legislators, particularly those focused on public health and safety. Many advocates argue that enhancing reporting requirements will lead to better regulation and oversight, ultimately benefiting patients and reducing the instances of drug misuse. However, there are voices of contention, particularly from some healthcare providers who express concerns about the potential for increased paperwork and the fear that stricter regulations may inadvertently hinder patient care.

Contention

Notable points of contention include the balance between necessary regulation and the operational realities faced by healthcare entities. Critics argue that while the bill's goals are laudable, the added compliance requirements could stifle the ability of healthcare providers to deliver timely service. Moreover, there are concerns about privacy and patient confidentiality as more data on prescriptions and controlled substance usage are systematically collected and analyzed under the new framework.

Companion Bills

No companion bills found.

Similar Bills

CA SB1009

Health and human services.

CA AB887

Gender.

CA SB863

Workers' compensation.

CA AB1484

Community redevelopment.

CA SB1008

Public social services: Medi-Cal.

CA SB1020

Public Safety Realignment.

CA SB806

State employees: military leave: salary overpayment.

CA AB1527

Firearms.